Torrent Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
February 02, 2024 at 03:23 am EST
Share
Torrent Pharmaceuticals Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 26,910 million compared to INR 24,590 million a year ago. Revenue was INR 26,990 million compared to INR 24,810 million a year ago. Net income was INR 4,430 million compared to INR 2,920 million a year ago. Basic earnings per share from continuing operations was INR 13.1 compared to INR 8.63 a year ago. Diluted earnings per share from continuing operations was INR 13.1 compared to INR 8.63 a year ago.
For the nine months, sales was INR 78,670 million compared to INR 70,120 million a year ago. Revenue was INR 80,100 million compared to INR 71,650 million a year ago. Net income was INR 12,070 million compared to INR 9,580 million a year ago. Basic earnings per share from continuing operations was INR 35.67 compared to INR 28.3 a year ago. Diluted earnings per share from continuing operations was INR 35.67 compared to INR 28.3 a year ago.
Torrent Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is focused on various therapeutic segments, such as cardiovascular (CV), central nervous system (CNS), gastrointestinal (GI), vitamins minerals nutrients (VMN), anti-diabetes (AD), pain, gynecology, and dermatology. The Company is engaged in research, development, manufacturing, marketing and distribution of branded and generic pharmaceutical formulations in India and internationally. Its pediatric product brands include Tedibar, Atogla, Spoo and B4 Nappi. Its acne/facecare products brands include Clinmiskin, ACNEMOIST, TRACNILO and fash. The Company's hair/scalp care products brands include Proanagen, Perlice, Permite and NOSKURF. Its manufacturing facilities are located in the states of Gujarat, Himachal Pradesh, Madhya Pradesh, Andhra Pradesh and Sikkim. The Company's primary channel of distribution is through the wholesale drug distributors, stockiest and retail pharmacies.
TORRENT PHARMACEUTICALS LIMITED 
